K. Rehse et F. Brehme, New NO donors with antithrombotic and vasodilating activities, part 26 amidoximes and their prodrugs, ARCH PHARM, 331(12), 1998, pp. 375-379
Seventeen amidoximes (2a-q) comprising aliphatic (2a-d), aromatic (2e-n), a
nd bis compounds (2o-q) have been synthesized. In the Born rest 4-chlorophe
nylethenecarboxamidoxime (21) was most active and inhibited the blood plate
let aggregation induced by collagen with an IC50 = 3 mu M. After oral admin
istration to rats (60 mg/kg) fourteen compounds significantly inhibited the
formation of thrombi in arterioles and venules. The strongest effect was o
bserved with ethene-bis-carboxamidoxime (2q) (31% in arterioles and 18% in
venules). The O-ethoxycarbonylderivatives 3 and the corresponding 1,2, 4-ox
adiazol-5-ones 4, which had been synthesized as prodrugs, showed smaller an
tithrombotic effects.